Clinical Trial Update: Novel Therapy for Glucose Intolerance in HIV Disease

View source ↗

Summary

A clinical trial evaluating a novel therapy for glucose intolerance in HIV infection has completed, reporting results on insulin resistance outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Insulin Resistance

Drugs mentioned

• Investigational therapy for glucose intolerance in HIV disease

Snippet

Sponsor: Stony Brook University | Conditions: Insulin Resistance | Status: COMPLETED